HLIQ Oncology

Customized Insights.
Improved outcomes.

HLI supports oncologists and their patients with genomics-powered health intelligence to guide decisions about personalized cancer therapy.

Learn More


HLIQ Oncology provides exome sequencing of the patient’s normal (or germline) DNA and tumor DNA to identify the targets that may be driving the patient’s specific cancer. HLIQ Oncology provides additional information on the mutational burden of the tumor to further guide treatment options, including if a patient is a candidate for immunotherapy.

HLIQ Oncology can:

  • Identify related mutations specific to the tumor that may explain the cancer
  • Identify if a patient may benefit from immunotherapy
  • Determine inherited cancer risk
  • Identify opportunities for off-label use of an approved drug
  • Identify opportunities for clinical trial participation
Physician Portal


Contact an HLI Oncology specialist to learn more, get started now, or ask specific questions.

Support through screening, diagnosis, and treatment

Learn more about HLI Oncology products

Please enter your first name.
Please enter your phone number.
Physician is required.
Please enter your last name.
Please enter your email address.
Organization Name is required.